The role of probiotics in COVID-19 treatment: Gut microbiota can help physicians in the outbreak

Kaynakça (1)

1. D Wang, B Hu, C Hu, et al. Clinical characteristics of 138 hospi-talized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323: 1061-9. [Crossref] 2. Gu J, Han B, Wang J. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology 2020; 158: 1518-9. [Crossref] 3. Doremalen N van, Bushmaker T, Morris DH, et al. Aerosol and Sur-face Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med 2020; 382: 1564-7. [Crossref] 4. Maslowski KM, Mackay CR. Diet, gut microbiota and immune re-sponses. Nat Immunol 2011; 12: 5-9. [Crossref] 5. Hanada S, Pirzadeh M, Carver KY, Deng JC. Respiratory Viral In-fection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia. Front Immunol 2018; 9: 2640. [Crossref] 6. Brown RL, Sequeira RP, Clarke TB. The microbiota protects against respiratory infection via GM-CSF signaling. Nat Commun 2017; 8: 1512. [Crossref] 7. Schuijt TJ, Lankelma JM, Scicluna BP, et al. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut 2016; 65: 575-83. [Crossref]